Clinical Trial Update: A Study of FVIII Gene Therapy for Hemophilia A [EARLY_Phase 1]

View source ↗

Summary

A Phase I study investigating Factor VIII gene therapy for Hemophilia A is currently recruiting in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• FVIII gene therapy (Factor VIII gene therapy)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hemophilia A | EARLY_Phase 1 | Status: RECRUITING